STTK
Shattuck Labs, Inc.
NASDAQ · USHealthcareBiotechnology
$6.82-9.43%
Price as of Jul 20, 2026
STTK profitability
Shattuck Labs, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- -843.8%
- EBITDA margin
- -4623.1%
- EBIT margin
- -5266.4%
- Net margin
- -4987.4%
- Free cash flow margin
- -4128.2%
Returns
- Return on equity
- -52.0%
- Return on assets
- -48.8%
- Return on invested capital
- -53.3%
- Asset turnover
- 0.01x
Cash efficiency
- Cash from operations
- -$41.3M
- Cash per share
- $1.18
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.